FindTrial
Sign In

A novel detection method for quantification of miRNA in peripheral blood for thyroid carcinoma diagnosis

A novel detection method for quantification of miRNA in peripheral blood for thyroid carcinoma diagnosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051540
Enrollment
Unknown
Registered
2021-09-26
Start date
2021-10-30
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid carcinoma

Interventions

is&#32
regarded&#32
as&#32
a&#32
biomarker.
Gold Standard:Histopathological result of thyroid tumor tissue samples
Index test:Serum&#32
miRNA&#32

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily participate in this project and sign the informed consent; 2. Age 18-70 years old (including boundary values); 3. Patients with thyroid nodules who are suggested to be operated on by thyroid ultrasonography; or patients with suspected malignant tumors; or patients with large nodules with obvious compression symptoms; or retrosternal goiter.

Exclusion criteria

Exclusion criteria: 1. Vulnerable groups, such as people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, etc.; 2. Patients with heart, lung, kidney and other organ diseases.

Design outcomes

Primary

MeasureTime frame
serum miRNA;—

Countries

China

Contacts

Public ContactCai Sheng

College of Pharmaceutical Sciences, Zhejiang University

caisheng@zju.edu.cn+86 13777575047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026